An antineoplastic C14-labeled methylhydrazine derivative in P815 mouse leukemia. A metabolic study.
D000478:Alkylation; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D002247:Carbon Isotopes; D002854:Chromatography, Paper; D004273:DNA, Neoplasm / Q000378:metabolism*; D006834:Hydrazines / Q000378:metabolism*; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000378:metabolism*; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000378:metabolism*; D011874:Radiometry; D013057:Spectrum Analysis
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D006834:Hydrazines; D009363:Neoplasm Proteins; D010743:Phospholipids; D012334:RNA, Neoplasm
J Natl Cancer Inst. 1957 Apr;18(4):587-601
13416911
J Biol Chem. 1948 Aug;175(1):315-32
18873306
J Biol Chem. 1946 Aug;164(2):747-51
21001169
Experientia. 1963 Mar 15;19:132-3
13971061
Biochem J. 1951 May;48(5):584-90
14838906
Experientia. 1964 Jan 15;20(1):38-9
5850497
Experientia. 1963 Mar 15;19:131-2
13975694
Experientia. 1963 Mar 15;19:129
14003433